The tryptophan catabolite or kynurenine pathway in major depressive and bipolar disorder: A systematic review and meta-analysis
Background: There is now evidence that affective disorders including major depressive disorder (MDD) and bipolar disorder (BD) are mediated by immune-inflammatory and nitro-oxidative pathways. Activation of these pathways may be associated with activation of the tryptophan catabolite (TRYCAT) pathwa...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-12-01
|
| Series: | Brain, Behavior, & Immunity - Health |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666354622001272 |
| _version_ | 1797991294286430208 |
|---|---|
| author | Abbas F. Almulla Yanin Thipakorn Asara Vasupanrajit Ali Abbas Abo Algon Chavit Tunvirachaisakul Ashwan Abdulzahra Hashim Aljanabi Gregory Oxenkrug Hussein K. Al-Hakeim Michael Maes |
| author_facet | Abbas F. Almulla Yanin Thipakorn Asara Vasupanrajit Ali Abbas Abo Algon Chavit Tunvirachaisakul Ashwan Abdulzahra Hashim Aljanabi Gregory Oxenkrug Hussein K. Al-Hakeim Michael Maes |
| author_sort | Abbas F. Almulla |
| collection | DOAJ |
| description | Background: There is now evidence that affective disorders including major depressive disorder (MDD) and bipolar disorder (BD) are mediated by immune-inflammatory and nitro-oxidative pathways. Activation of these pathways may be associated with activation of the tryptophan catabolite (TRYCAT) pathway by inducing indoleamine 2,3-dioxygenase (IDO, the rate-limiting enzyme) leading to depletion of tryptophan (TRP) and increases in tryptophan catabolites (TRYCATs). Aims: To systematically review and meta-analyze central and peripheral (free and total) TRP levels, its competing amino-acids (CAAs) and TRYCATs in MDD and BD. Methods: This review searched PubMed, Google Scholar and SciFinder and included 121 full-text articles and 15470 individuals, including 8024 MDD/BD patients and 7446 healthy controls. Results: TRP levels (either free and total) and the TRP/CAAs ratio were significantly decreased (p < 0.0001) in MDD/BD as compared with controls with a moderate effect size (standardized mean difference for TRP: SMD = −0.513, 95% confidence interval, CI: −0.611; −0.414; and TRP/CAAs: SMD = −0.558, CI: −0.758; −0.358). Kynurenine (KYN) levels were significantly decreased in patients as compared with controls with a small effect size (p < 0.0001, SMD = −0.213, 95%CI: −0.295; −0.131). These differences were significant in plasma (p < 0.0001, SMD = −0.304, 95%CI: −0.415, −0.194) but not in serum (p = 0.054) or the central nervous system (CNS, p = 0.771). The KYN/TRP ratio, frequently used as an index of IDO activity, and neurotoxicity indices based on downstream TRYCATs were unaltered or even lowered in MDD/BD. Conclusions: Our findings suggest that MDD and BD are accompanied by TRP depletion without IDO and TRYCAT pathway activation. Lowered TRP availability is probably the consequence of lowered serum albumin during the inflammatory response in affective disorders. |
| first_indexed | 2024-04-11T08:49:45Z |
| format | Article |
| id | doaj.art-9072ed3a43e844899d2803b1ced3115c |
| institution | Directory Open Access Journal |
| issn | 2666-3546 |
| language | English |
| last_indexed | 2024-04-11T08:49:45Z |
| publishDate | 2022-12-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Brain, Behavior, & Immunity - Health |
| spelling | doaj.art-9072ed3a43e844899d2803b1ced3115c2022-12-22T04:33:45ZengElsevierBrain, Behavior, & Immunity - Health2666-35462022-12-0126100537The tryptophan catabolite or kynurenine pathway in major depressive and bipolar disorder: A systematic review and meta-analysisAbbas F. Almulla0Yanin Thipakorn1Asara Vasupanrajit2Ali Abbas Abo Algon3Chavit Tunvirachaisakul4Ashwan Abdulzahra Hashim Aljanabi5Gregory Oxenkrug6Hussein K. Al-Hakeim7Michael Maes8Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; Medical Laboratory Technology Department, College of Medical Technology, The Islamic University, Najaf, IraqDepartment of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, ThailandDepartment of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, ThailandIraqi Education Ministry, Najaf, IraqDepartment of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; Cognitive Impairment and Dementia Research Unit, Faculty of Medicine, Chulalongkorn University, Bangkok, ThailandDepartment of Psychiatry, Faculty of Medicine, University of Kufa, Iraq; Department of Psychiatry Al-Hakeem General Hospital, IraqDepartment of Psychiatry, Tufts University School of Medicine and Tufts Medical Center, Boston, MA, 02111, USADepartment of Chemistry, College of Science, University of Kufa, Kufa, IraqDepartment of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; Department of Psychiatry, Medical University of Plovdiv, Plovdiv, Bulgaria; Department of Psychiatry, IMPACT Strategic Research Centre, Deakin University, Geelong, Victoria, Australia; Corresponding author. Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, 10330, Thailand.Background: There is now evidence that affective disorders including major depressive disorder (MDD) and bipolar disorder (BD) are mediated by immune-inflammatory and nitro-oxidative pathways. Activation of these pathways may be associated with activation of the tryptophan catabolite (TRYCAT) pathway by inducing indoleamine 2,3-dioxygenase (IDO, the rate-limiting enzyme) leading to depletion of tryptophan (TRP) and increases in tryptophan catabolites (TRYCATs). Aims: To systematically review and meta-analyze central and peripheral (free and total) TRP levels, its competing amino-acids (CAAs) and TRYCATs in MDD and BD. Methods: This review searched PubMed, Google Scholar and SciFinder and included 121 full-text articles and 15470 individuals, including 8024 MDD/BD patients and 7446 healthy controls. Results: TRP levels (either free and total) and the TRP/CAAs ratio were significantly decreased (p < 0.0001) in MDD/BD as compared with controls with a moderate effect size (standardized mean difference for TRP: SMD = −0.513, 95% confidence interval, CI: −0.611; −0.414; and TRP/CAAs: SMD = −0.558, CI: −0.758; −0.358). Kynurenine (KYN) levels were significantly decreased in patients as compared with controls with a small effect size (p < 0.0001, SMD = −0.213, 95%CI: −0.295; −0.131). These differences were significant in plasma (p < 0.0001, SMD = −0.304, 95%CI: −0.415, −0.194) but not in serum (p = 0.054) or the central nervous system (CNS, p = 0.771). The KYN/TRP ratio, frequently used as an index of IDO activity, and neurotoxicity indices based on downstream TRYCATs were unaltered or even lowered in MDD/BD. Conclusions: Our findings suggest that MDD and BD are accompanied by TRP depletion without IDO and TRYCAT pathway activation. Lowered TRP availability is probably the consequence of lowered serum albumin during the inflammatory response in affective disorders.http://www.sciencedirect.com/science/article/pii/S2666354622001272Neuro-immuneAffective disordersInflammationOxidative and nitrosative stressPsychiatryNeurotoxicity |
| spellingShingle | Abbas F. Almulla Yanin Thipakorn Asara Vasupanrajit Ali Abbas Abo Algon Chavit Tunvirachaisakul Ashwan Abdulzahra Hashim Aljanabi Gregory Oxenkrug Hussein K. Al-Hakeim Michael Maes The tryptophan catabolite or kynurenine pathway in major depressive and bipolar disorder: A systematic review and meta-analysis Brain, Behavior, & Immunity - Health Neuro-immune Affective disorders Inflammation Oxidative and nitrosative stress Psychiatry Neurotoxicity |
| title | The tryptophan catabolite or kynurenine pathway in major depressive and bipolar disorder: A systematic review and meta-analysis |
| title_full | The tryptophan catabolite or kynurenine pathway in major depressive and bipolar disorder: A systematic review and meta-analysis |
| title_fullStr | The tryptophan catabolite or kynurenine pathway in major depressive and bipolar disorder: A systematic review and meta-analysis |
| title_full_unstemmed | The tryptophan catabolite or kynurenine pathway in major depressive and bipolar disorder: A systematic review and meta-analysis |
| title_short | The tryptophan catabolite or kynurenine pathway in major depressive and bipolar disorder: A systematic review and meta-analysis |
| title_sort | tryptophan catabolite or kynurenine pathway in major depressive and bipolar disorder a systematic review and meta analysis |
| topic | Neuro-immune Affective disorders Inflammation Oxidative and nitrosative stress Psychiatry Neurotoxicity |
| url | http://www.sciencedirect.com/science/article/pii/S2666354622001272 |
| work_keys_str_mv | AT abbasfalmulla thetryptophancataboliteorkynureninepathwayinmajordepressiveandbipolardisorderasystematicreviewandmetaanalysis AT yaninthipakorn thetryptophancataboliteorkynureninepathwayinmajordepressiveandbipolardisorderasystematicreviewandmetaanalysis AT asaravasupanrajit thetryptophancataboliteorkynureninepathwayinmajordepressiveandbipolardisorderasystematicreviewandmetaanalysis AT aliabbasaboalgon thetryptophancataboliteorkynureninepathwayinmajordepressiveandbipolardisorderasystematicreviewandmetaanalysis AT chavittunvirachaisakul thetryptophancataboliteorkynureninepathwayinmajordepressiveandbipolardisorderasystematicreviewandmetaanalysis AT ashwanabdulzahrahashimaljanabi thetryptophancataboliteorkynureninepathwayinmajordepressiveandbipolardisorderasystematicreviewandmetaanalysis AT gregoryoxenkrug thetryptophancataboliteorkynureninepathwayinmajordepressiveandbipolardisorderasystematicreviewandmetaanalysis AT husseinkalhakeim thetryptophancataboliteorkynureninepathwayinmajordepressiveandbipolardisorderasystematicreviewandmetaanalysis AT michaelmaes thetryptophancataboliteorkynureninepathwayinmajordepressiveandbipolardisorderasystematicreviewandmetaanalysis AT abbasfalmulla tryptophancataboliteorkynureninepathwayinmajordepressiveandbipolardisorderasystematicreviewandmetaanalysis AT yaninthipakorn tryptophancataboliteorkynureninepathwayinmajordepressiveandbipolardisorderasystematicreviewandmetaanalysis AT asaravasupanrajit tryptophancataboliteorkynureninepathwayinmajordepressiveandbipolardisorderasystematicreviewandmetaanalysis AT aliabbasaboalgon tryptophancataboliteorkynureninepathwayinmajordepressiveandbipolardisorderasystematicreviewandmetaanalysis AT chavittunvirachaisakul tryptophancataboliteorkynureninepathwayinmajordepressiveandbipolardisorderasystematicreviewandmetaanalysis AT ashwanabdulzahrahashimaljanabi tryptophancataboliteorkynureninepathwayinmajordepressiveandbipolardisorderasystematicreviewandmetaanalysis AT gregoryoxenkrug tryptophancataboliteorkynureninepathwayinmajordepressiveandbipolardisorderasystematicreviewandmetaanalysis AT husseinkalhakeim tryptophancataboliteorkynureninepathwayinmajordepressiveandbipolardisorderasystematicreviewandmetaanalysis AT michaelmaes tryptophancataboliteorkynureninepathwayinmajordepressiveandbipolardisorderasystematicreviewandmetaanalysis |